Long term clinical outcomes in patients with moderate renal insufficiency undergoing stent based percutaneous coronary intervention

Chinese Medical Journal

Volumn 119, Issue 14, 2006, Pages 1176-1181

  Zhang, Rui Yan ^a   Ni, Jing Wei ^a   Zhang, Jian Sheng ^a   Hu , Jian ^a   Yang, Zhen Kun ^a   Zhang, Qi ^a   Lü, An Kang ^a   Shen, Wei Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Drug eluting stent; Long term outcome; Percutaneous coronary intervention; Renal insufficiency

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CHINA; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; CREATININE CLEARANCE; CREATININE URINE LEVEL; DISEASE SEVERITY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; TREATMENT OUTCOME;

EID: 33746373839     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200607020-00007     Document Type: Article

References (24)

1. Wolfe RA, Port FK, Webb RL, Bloembergen WE, Hirth R, Young EW, et al. Introduction to the excerpts from the United States renal data system 1999 annual data report. Am J Kidney Dis 1999;34 (2 Suppl 1):S1-S3.
2. Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Hartzler GO. Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 1990; 119:484-489.
3. Koyanagi T, Nishida H, Kitamura M, Endo M, Koyanagi H, Kawaguchi M, et al. Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in renal dialysis patients. Ann Thorac Surg 1996;61:1793-1796.
4. Schoebel FC, Gradaus F, Ivens K, Heering P, Jax TW, Grabensee B, et al. Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography. Heart 1997;78:337-342.
5. Regar E, Serruys PW, Bode C, Holubarsch C, Guermonprez JL, Wijns W, et al. Angiographic findings of the multicenter randomized study with the sirolimus-eluting Bx velocity balloon-expandable stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size. Circulation 2002;106:1949-1956.
6. Ni J, Zhang RY, Hu J, Zhang X, Zheng AF, Shen WF. Long term outcomes of percutaneous renal interventional therapy in patients with severe renal artery stenosis. Chin J Interv Cardiol (Chin) 2005; 13:284-286.
7. Zhang RY, Shen WF, Zhng JS. Zhang DD, Zhang X, Zheng AF. Emergent coronary stenting for unstable angina. Chin J Cardiol (Chin) 2000; 28: 423-425.
8. Zhang Q, Shen WF, Zhang RY, Zhang JS, Hu J, Zhang X. The Summary of 847 Consecutive Patients Underwent Selective Renal Angiography Immediately after Coronary Angiography. Chin J Arterioscler (Chin) 2003; 11: 254-256.
9. Zhang RY, Shen WF. Chronic renal disease and cardiovascular disease. Chin J Interv Cardiol (Chin) 2004;19:234-235.
10. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58: 353-362.
11. He J, Whelton PK. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. J Hypertens Suppl 1999;17: S7-S13.
12. Keane WF, Collins AJ. Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis 1994; 24:1010-1018.
13. Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst (e) inemia in humans. Circulation 1999; 100:1161-1168.
14. Herrmann W, Quast S, Ellgass A, Wolter K, Kiessig ST, Molinari E, et al. An increased serum level of free Apo(a) in renal patients is more striking than that of Lp(a) and is influenced by homocysteine. Nephron 2000;85:41-49.
15. Romanic AM, Arleth AJ, Willette RN, Ohlstein EH. Factor XIIIa cross-links lipoprotein(a) with fibrinogen and is present in human atherosclerotic lesions. Circ Res 1998; 83:264-269.
16. Kiamk E, Solski J, Janicka L, Zagojska M. Lipid and lipoprotein ratios as risk factors of atherosclerosis in patients with chronic renal insufficiency. Int Urol Nephrol 1999; 31:263-267.
17. Shoji T, Nishizawa Y, Kawagishi T, Tanaka M, Kawasaki K, Tabata T, et al. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by dialysis. Atherosclerosis 1997; 131:229-236.
18. Schettler V, Wieland E, Methe H, Schuff-Werner P, Muller GA. Oxidative stress during dialysis: effect on free radical scavenging enzyme (FRSE) activities and glutathione (GSH) concentration in granulocytes. Nephrol Dial Transplant 1998; 13:2588-2593.
19. Gesquiere L, Loreau N, Minnich A, Davignon J, Blache D. Oxidative stress leads to cholesterol accumulation in vascular smooth muscle cells. Free Radic Biol Med 1999; 27:134-145.
20. Le Feuvre C, Dambrin G, Helft G, Tabet S, Beygui F, Legendre C, et al. Comparison of clinical outcome following coronary stenting or balloon angioplasty in dialysis versus non-dialysis patients. Am J Cardiol 2000;85:1365-1368.
21. Manske CL, Wang Y, Rector T, Wilson RF, White CW. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992;340:998-1002.
22. Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002; 39:1113-1119.
23. Urban P, Gershlick AH, Guagliumi G, Guyon P, Lotan C, Schofer J, et al. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation 2006;113:1434-1441.
24. Lopez-Minguez JR, Nogales JM, Morales A, Alonso R, Gonzalez R, Merchan A. Clinical and angiographic followup in patients with Cypher or Taxus stents in populations with high percentage of trial-excluded lesions. Cardiovasc Revasc Med 2005; 6:92-98.